No Data
No Data
Express News | GlucoTrack Inc - Aggregate Offering Price up to $8.23 Million
Express News | GlucoTrack Inc - Enters Atm Sales Agreement With Dawson James
Glucotrack, Inc. Commences Feasibility Study for Novel Continuous Blood Glucose Monitor With Results Expected in 6-8 Weeks
Glucotrack Announces Start Of Enrollment For Human Clinical Study Of Continuous Blood Glucose Monitor; Study Will Focus On The Co's Continuous Blood Glucose Monitor And Will Include Participants With Both Type 1 And Type 2 Diabetes
GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR
Express News | GlucoTrack Announces Start of Enrollment for Human Clinical Study of Continuous Blood Glucose Monitor